ArticleOncology letters2024

Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.

Akifumi Kuwano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.